ADIMMUNE CORPORATION — Investor Relations & Filings
ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司115年第1季財務報告提報董事會召開日期 | 2026-05-06 | Chinese | |
| 115年年報及股東會資料 — 2026_4142_20260604FE2.pdf | 2026-04-29 | English | |
| 115年年報及股東會資料 — 2026_4142_20260604F13.pdf | 2026-04-29 | Chinese | |
| 115年年報及股東會資料 — 2026_4142_20260604F02.pdf | 2026-04-29 | Chinese | |
| 115年年報及股東會資料 — 2026_4142_20260604FE1.pdf | 2026-04-29 | English | |
| 115年年報及股東會資料 — 2026_4142_20260604F01.pdf | 2026-04-29 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41701646 | 公告本公司115年第1季財務報告提報董事會召開日期 | 2026-05-06 | Chinese | ||
| 39931828 | 115年年報及股東會資料 — 2026_4142_20260604FE2.pdf | 2026-04-29 | English | ||
| 39931813 | 115年年報及股東會資料 — 2026_4142_20260604F13.pdf | 2026-04-29 | Chinese | ||
| 39931797 | 115年年報及股東會資料 — 2026_4142_20260604F02.pdf | 2026-04-29 | Chinese | ||
| 38408811 | 115年年報及股東會資料 — 2026_4142_20260604FE1.pdf | 2026-04-29 | English | ||
| 38408788 | 115年年報及股東會資料 — 2026_4142_20260604F01.pdf | 2026-04-29 | Chinese | ||
| 35606592 | 公司基本資料 | 2026-04-23 | Chinese | ||
| 35222612 | 公告本公司董事會決議召開115年股東會相關事宜(增列報告事項) | 2026-04-22 | Chinese | ||
| 35222620 | 公告本公司稽核主管異動 | 2026-04-22 | Chinese | ||
| 33889235 | 115年03月內部人持股異動(事後) | 2026-04-09 | Chinese | ||
| 33889234 | 115年03月董事會成員及持股 | 2026-04-09 | Chinese | ||
| 33874619 | 115年3月背書保證與資金貸與 | 2026-04-09 | Chinese | ||
| 33874617 | 115年3月營業收入 | 2026-04-09 | Chinese | ||
| 34544871 | 114年度財務比率 | 2026-03-31 | Chinese | ||
| 34544874 | 114年第4季海外子公司投資 | 2026-03-31 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AMINOLOGICS CO.,LTD.
Specialty manufacturer of high-purity chiral amino acids an…
|
074430 | KR | Manufacturing |
|
Amneal Pharmaceuticals, Inc.
Develops, manufactures, and distributes generic and special…
|
AMRX | US | Manufacturing |
|
Amoy Diagnostics Co.,Ltd.
Develops molecular diagnostic kits and companion diagnostic…
|
300685 | CN | Manufacturing |
|
Amphastar Pharmaceuticals, Inc.
Develops, manufactures, and markets technically challenging…
|
AMPH | US | Manufacturing |
|
Amrutanjan Health Care Limited
Develops and distributes over-the-counter healthcare and pe…
|
AMRUTANJAN | IN | Manufacturing |
|
Amwill Health Care Limited
Develops, manufactures, and distributes a wide range of med…
|
544353 | IN | Manufacturing |
|
Amylyx Pharmaceuticals, Inc.
Develops therapies for neurodegenerative diseases and other…
|
AMLX | US | Manufacturing |
|
AN2 Therapeutics, Inc.
Biopharmaceutical firm developing boron-based drugs for inf…
|
ANTX | US | Manufacturing |
|
Ananda Pharma Plc
Biopharmaceutical firm developing cannabinoid-based medicin…
|
ANAN | GB | Manufacturing |
|
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
Designs, develops, and manufactures molecular diagnostic so…
|
ANGEN | TR | Manufacturing |
ADIMMUNE CORPORATION via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52386/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52386 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52386 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52386 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52386}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ADIMMUNE CORPORATION (id: 52386)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.